Assessment of pulmonary surfactant in COVID-19 patients

Assessment of pulmonary surfactant in COVID-19 patients

Keywords: COVID-19, ARDS, Pulmonary surfactant

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care (London, England) England), 2020-09, Vol.24 (1), p.552-552, Article 552
Hauptverfasser: Schousboe, Peter, Wiese, Lothar, Heiring, Christian, Verder, Henrik, Poorisrisak, Porntiva, Verder, Povl, Nielsen, Henning Bay
Format: Artikel
Sprache:eng
Schlagworte:
Adult respiratory distress syndrome
Analysis
ARDS
Clinical trials
Coronavirus Infections - complications
Coronavirus Infections - therapy
Coronaviruses
COVID-19
Critical care
Humans
Intensive care
Letter
Lung diseases
Neonatology
Newborn babies
Pandemics
Pathophysiology
Permeability
Pneumonia
Pneumonia, Viral - complications
Pneumonia, Viral - therapy
Premature birth
Pulmonary surfactant
Pulmonary Surfactants - analysis
Respiratory distress syndrome
Respiratory Distress Syndrome - virology
Sepsis
Severe acute respiratory syndrome coronavirus 2
Spectrum analysis
Surface active agents
Surfactants
Ventilators
Ventilators (Medical equipment)
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Keywords: COVID-19, ARDS, Pulmonary surfactant
ISSN:1364-8535
1466-609X
1364-8535
1366-609X
DOI:10.1186/s13054-020-03268-9